Over the years, as Sanofi and Regeneron’s Dupixent racked up new indications and approached the French pharma giant’s 10 billion euro peak sales goal, analysts had started …

We’re seeing victory laps these days during the Summer Olympic Games. Now it’s Pfizer’s turn. Three months after estimating 2021 revenues for its COVID-19 vaccine …